Unichem Labs gets USFDA approval for Tadalafil Tablets Farhat Nasim30 March 2019 9:30 AM ISTTadalafil tablets are a generic version of Eli Lilly's Cialis tablets. The drug is indicated for the treatment of erectile dysfunction (ED), the signs...
New York sues billionaire family behind maker of OxyContin Garima30 March 2019 9:00 AM ISTNEW YORK: New York is suing the billionaire family behind the company that created OxyContin, joining a growing list of state and local governments...
Zydus Cadila gets USFDA nod for Ambrisentan tablets to treat high BP Farhat Nasim29 March 2019 3:17 PM ISTAmbrisentan tablets would be manufactured at Zydus Cadila's formulations manufacturing facility at SEZ, Ahmedabad.New Delhi: Drug maker Zydus Cadila...
Lupin launches generic version of Lidex Ointment Farhat Nasim29 March 2019 1:18 PM ISTLupin's Fluocinonide Ointment USP, 0.05%, is the generic version of County Line Pharmaceuticals LLC's Lidex Ointment 0.05%. It is indicated for the...
Cancer Causing Talcum Powder: JnJ gets New Jersey jury relief Medical Dialogues Bureau29 March 2019 11:40 AM ISTJnJ on Wednesday also settled three other mesothelioma talc cases pending in state courts in California, Oklahoma and New York, Chris Panatier, a...
Suven Life Sciences secures Product Patent in Brazil, Eurasia Garima29 March 2019 9:40 AM ISTThe granted claims of patents are being developed as therapeutic agents useful in treatment of cognitive impairment associated with neurodegenerative...
AstraZeneca, Daiichi Sankyo sign $6.9 billion cancer drug deal Garima29 March 2019 9:15 AM ISTUnder the deal, AstraZeneca will pay Daiichi up to $6.9 billion, including a $1.35 billion upfront payment. The two companies will share development...
Dr Reddy's launches Tadalafil Tablets to treat erectile dysfunction Farhat Nasim28 March 2019 12:06 PM ISTDr Reddy's Tadalafil tablets are available in four strengths including 2.5 mg, 5 mg, 10 mg, and 20 mg, each in 30-count bottle size.New Delhi: Dr...
Clarus Therapeutics gets USFDA nod to Jatenzo for treatment of hypogonadism Farhat Nasim28 March 2019 11:23 AM ISTThe efficacy of Jatenzo was demonstrated in a four-month clinical trial involving 166 men with hypogonadism.New Delhi: The U.S. Food and Drug...
Newly approved MS drug Mayzent priced at USD 88000: Novartis Garima28 March 2019 10:00 AM ISTNovartis has priced the treatment at $88,000 annually, head of pharmaceuticals Paul Hudson told Reuters, a level exceeding some other MS drugs and one...
Strides Pharma gets USFDA approval for Oral Dosage facility in Singapore Medical Dialogues Bureau28 March 2019 9:30 AM ISTWith the commercialisation of this facility, the Strides Pharma will join the league of global pharmaceutical companies having manufacturing and...
Purdue Pharma agrees to pay $270 million to settle opioid case Medical Dialogues Bureau28 March 2019 9:15 AM ISTPurdue Pharma introduced OxyContin in the 1990s and marketed it hard to doctors, making tens of billions of dollars from the drug. But the company has...
